TEVA PHARMACEUTICAL-SP ADR (TEVA) Institutional Ownership Changes & 13F Activity

TEVA PHARMACEUTICAL-SP ADR (TEVA). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings. This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Sound Shore Management, Greenlight Capital, ARK Invest, Sequoia Financial Advisors, and Viking Global Investors.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q4 2016Muhlenkamp & CoBuy64,119239,889$8,696
Q4 2016Matrix Advisors Value FundBuy1,742261,000$9,461
Q3 2016Viking Global InvestorsSell-8,052,43619,684,219$905,671
Q3 2016Renaissance Technologies LLCBuy560,2001,947,963$89,626
Q3 2016Matrix Advisors Value FundBuy23,786259,258$11,928
Q3 2016Muhlenkamp & CoSell-885175,770$8,087
Q2 2016Viking Global InvestorsSell-5,234,96727,736,655$1,393,212
Q2 2016First Eagle U.S. ValueSell-1,915,460200$10
Q2 2016Renaissance Technologies LLCBuy196,5001,387,763$69,707
Q2 2016Matrix Advisors Value FundBuy5,170235,472$11,828
Q2 2016Muhlenkamp & CoSell-505176,655$8,873
Q1 2016Viking Global InvestorsBuy7,927,84732,971,622$1,764,311
Q1 2016First Eagle U.S. ValueSell-2,455,9591,915,660$102,507
Q1 2016Renaissance Technologies LLCBuy658,7631,191,263$63,744
Q1 2016Matrix Advisors Value FundBuy3,353230,302$12,323
Q1 2016Muhlenkamp & CoBuy205177,160$9,480
Q4 2015Viking Global InvestorsBuy16,171,12525,043,775$1,643,873
Q4 2015Renaissance Technologies LLCSell-2,346,263532,500$34,953
Q4 2015Matrix Advisors Value FundSell-121,350226,949$14,897
Q4 2015First Eagle U.S. ValueSell-95,3924,371,619$286,953
Q3 2015Viking Global InvestorsBuy8,644,0508,872,650$500,950
Q3 2015Renaissance Technologies LLCBuy803,0002,878,763$162,535
Q3 2015First Eagle U.S. ValueBuy710,0134,467,011$252,207
Q3 2015Matrix Advisors Value FundSell-14,559348,299$19,665
Q3 2015Muhlenkamp & CoBuy40176,955$9,991
Q2 2015Renaissance Technologies LLCBuy736,8002,075,763$122,678
Q2 2015First Eagle U.S. ValueSell-448,4833,756,998$222,039
Q2 2015Matrix Advisors Value FundSell-5,245362,858$21,445
Q2 2015Muhlenkamp & CoBuy205176,915$10,456
Q1 2015First Eagle U.S. ValueBuy1,757,1714,205,481$262,002

Frequently asked questions about TEVA activity

  • Which institutional owners are buying TEVA?

    Institutional owners buying TEVA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in TEVA activity?

    "Buy" means an investor increased their reported position in TEVA compared to the prior reporting period. This reflects growing exposure to TEVA PHARMACEUTICAL-SP ADR (TEVA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in TEVA increasing?

    Institutional interest in TEVA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related TEVA Institutional Insights